Stanton Glantz, PhD's blog

Father Michael Crosby, long-time friend and tobacco control leader, passes away

I was saddened to learn that Father Michael Crosby recently passed away from cancer.  Mike was an early leader in the movement to put shareholder pressure on the tobacco companies over their unethical marketing practices and for more than a decade was a leader among shareholder groups to put pressure on the media companies to get smoking out of youth-rated films.  As the CDC MMWR recently noted, this investor pressure has been an important element in the progress, albeit incomplete, that we have made to date.
  Read more »

How Colombia resisted Big Tobacco and implemented strong advertising restrictions and health warning labels

Randy Uang, Eric Crosbie, and I just published Tobacco control law implementation in a middle-income country: Transnational tobacco control network overcoming tobacco industry opposition in Colombia in Global Public Health  This paper shows how, with strategic assistance from the global tobacco control community, Colombia was able to defend and implement strong legislation restricting advertising, promotion, and sponsorship as well as strong health warning labels, consistent with the FCTC. Read more »

What the tobacco companies know about NRT: Without counselling, it keeps people smoking

Dorie Apollonio and I just published “Tobacco Industry Research on Nicotine Replacement Therapy: “If Anyone Is Going to Take Away Our Business It Should Be Us” in American Journal of Public Health.  This paper uses previously secret tobacco industry documents to show that the cigarette companies were originally afraid that nicotine replacement therapy, combined with counselling, would cost them customers.
  Read more »

What the tobacco companies know about NRT: Without counselling, it keeps people smoking

Dorie Apollonio and I just published “Tobacco Industry Research on Nicotine Replacement Therapy: “If Anyone Is Going to Take Away Our Business It Should Be Us” in American Journal of Public Health.  This paper uses previously secret tobacco industry documents to show that the cigarette companies were originally afraid that nicotine replacement therapy, combined with counselling, would cost them customers.
  Read more »

More evidence to support eliminating flavors to reduce youth cigarette and e-cigarette use

Two recent papers demonstrate that flavors are an important reason that kids use cigarettes and e-cigarettes, supporting the importance of the kind of comprehensive ban on selling all flavored tobacco products, including menthol, that San Francisco passed and this is under assault by RJ Reynolds.
  Read more »

Marijuana associated with three-fold risk of death from hypertension

The evidence that marijuana imposes important cardiovascular disease risks continued to grow with the recent publication of “Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the National Health and Nutrition Examination Survey linked mortality file” by Barbara A Yankey and colleagues in the European Journal of Preventive CardiologyIt found that marijuana use was associated with more than a tripling of risk of death from hypertension.
  Read more »

Philip Morris’ claims about IQOS safety are attracting scrutiny

On August 11, 2017, the Washington Post ran a detailed story, “Big Tobacco’s new cigarette is sleek, smokeless — but is it any better for you?” that highlighted Philip Morris’ sensitivity to a paper published in JAMA Internal Medicine highlighting Read more »

More evidence that e-cigarettes have rapid negative effects on arteries

Interfering with normal functioning of arteries, both immediate effects on arteries’ ability to enlarge when the body needs more blood flow and longer term effects on arterial stiffness, are important mechanisms by which exposure to tobacco smoke causes heart disease and triggers heart attacks.
  Read more »

E-cigarettes and cancer: If you ask the wrong question you get the wrong answer

A new paper, “Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke,” just published in Tobacco Control, adds to the already-convincing literature that e-cigarettes expose users to much lower levels of carcinogens than conventional cigarettes do.
  Read more »

FDA’s “new” nicotine policy: A mixed picture that highlights the importance of local and state action to maintain progress

The FDA made big news last week (July 28, 2017) when it announced a “comprehensive nicotine strategy” last week that could include reducing the nicotine delivery from combusted cigarettes to below addictive levels.  If FDA actually implements such a policy in an effective way, that would be a big step forward.  (Whether or not such a policy would actually work in the real world was not clear until, over the last few years, the FDA has supported some Read more »

Syndicate content